Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update
Neuromuscular disorders encompass a heterogeneous group of conditions that impair the function of muscles, motor neurons, peripheral nerves, and neuromuscular junctions. Being the most common and most severe type of muscular dystrophy, Duchenne muscular dystrophy (DMD), is caused by mutations in the...
Main Authors: | Chengmei Sun, Luoan Shen, Zheng Zhang, Xin Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/11/8/837 |
Similar Items
-
Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies
by: Elisabeth Le Rumeur
Published: (2015-07-01) -
Promising therapeutic approaches of utrophin replacing dystrophin in the treatment of Duchenne muscular dystrophy
by: Ruo Wu, et al.
Published: (2022-11-01) -
CRISPR Therapeutics for Duchenne Muscular Dystrophy
by: Esra Erkut, et al.
Published: (2022-02-01) -
Innovative Therapeutic Approaches for Duchenne Muscular Dystrophy
by: Fernanda Fortunato, et al.
Published: (2021-02-01) -
Intellectual Ability in the Duchenne Muscular Dystrophy and Dystrophin Gene Mutation Location
by: Rasic Milic V., et al.
Published: (2014-12-01)